Trial Profile
Phase 1/2 Study of Human Menstrual Blood-derived Mesenchymal Stem Cells Transplantation for the Evaluation of the Efficacy and Safety in Patients With Liver Cirrhosis
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 14 Sep 2021
Price :
$35
*
At a glance
- Drugs Menstrual blood-derived mesenchymal stem cells (Primary)
- Indications Liver cirrhosis
- Focus Therapeutic Use
- Sponsors S-Evans Biosciences
- 20 May 2015 New trial record